Newsfeeds - Spark Newswire

1 minute read

PTC Therapeutics To Host Call To Discuss Results Of PTC518 Phase 1 Study For Huntington’s Disease Program Thursday, Sept. 23, 2021 At 8 a.m. EDT

Today, 7:18 PM

PTC Therapeutics, Inc. (NASDAQ:PTCT) will host a conference call to discuss the positive results from the PTC518 Phase 1 healthy volunteer study. The new results include HTT mRNA and protein lowering, as well as

PTCT

5 minute read

The Daily Biotech Pulse: Cara’s Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal

By Shanthi Rexaline

Today, 7:18 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23)

ABBV

1 minute read

PTC Therapeutics’ Waylivra Scores Approval In Brazil For Genetic Disorder

By Vandana Singh

Today, 7:18 PM

The Brazilian Health Regulatory Agency has approved PTC Therapeutics Inc’s (NASDAQ:PTCT) Waylivra (volanesorsen) as the first treatment for familial chylomicronemia syndrome…

IONS

1 minute read

PTC Therapeutics Announces Waylivra Approval In Brazil As First Treatment For Familial Chylomicronemia Syndrome

By Bill Haddad

Today, 7:18 PM

PTC Therapeutics, Inc. (NASDAQ:PTCT) today announced that the Brazilian Health Regulatory Agency, ANVISA (Agência Nacional de Vigilância Sanitária), has approved

PTCT

11 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 7:18 PM

On Friday morning, 155 companies achieved new lows for the year.

AAU

6 minute read

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen’s Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data

By Shanthi Rexaline

Today, 7:18 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19)

ABVC

22 minute read

Earnings Scheduled For July 29, 2021

By Benzinga Insights

Today, 7:18 PM

Companies Reporting Before The Bell • Smith & Nephew (NYSE:SNN) is projected to report earnings for its second quarter.

5 minute read

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer’s Conference, IPOs and More

By Shanthi Rexaline

Today, 7:18 PM

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season.

ABBV